Literature DB >> 31185253

Reactive oxygen species: The signal regulator of B cell.

Hushan Zhang1, Luman Wang2, Yiwei Chu3.   

Abstract

Reactive oxygen species (ROS) are indispensable for determining the fate of immune cells in both physiological and pathogenic environments, thus stimulating the interest of immunologists and clinicians. B cells are essential in maintaining immune homeostasis, and studies have indicated that ROS affect the maturation, activation and differentiation of B cells by controlling the signaling molecules in various molecular pathways. In the present review, we aimed to summarize the biological properties of ROS and the mechanisms by which ROS regulate B cell signaling pathways. We propose that ROS and their mediated signal transduction can be a new approach for manipulating B cell immune functions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; Reactive oxygen species; Signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 31185253     DOI: 10.1016/j.freeradbiomed.2019.06.004

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  4 in total

1.  Insight into the Impact of Oxidative Stress on the Barrier Properties of Lipid Bilayer Models.

Authors:  Zahra Nasri; Mohsen Ahmadi; Johanna Striesow; Mehdi Ravandeh; Thomas von Woedtke; Kristian Wende
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 2.  The Potential Role of Ferroptosis in Systemic Lupus Erythematosus.

Authors:  Qian Chen; Jie Wang; Mengmeng Xiang; Yilun Wang; Zhixiong Zhang; Jun Liang; Jinhua Xu
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

Review 3.  Metabolic ROS Signaling: To Immunity and Beyond.

Authors:  A Y Andreyev; Y E Kushnareva; N N Starkova; A A Starkov
Journal:  Biochemistry (Mosc)       Date:  2020-12       Impact factor: 2.487

4.  Promoting intestinal IgA production in mice by oral administration with anthocyanins.

Authors:  Xuerun Liu; Luoyang Wang; Huiren Zhuang; Zhenghuan Yang; Guoqiang Jiang; Zheng Liu
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.